Helping Patients with Cancer in Primary Care: The patient journey

One of the Community Pharmacy Primary Care Subcommittee Members, Pete Robertson is producing a series videos for BOPA to help promote ways Community and Primary Care colleagues can support patients with cancer.

The first video – Cancer Care Part 1 – The Patient Journey is out NOW on youtube.

The video is also available on Tiktok and Instagram.

The videos recommend the Let’s Communicate Cancer resource. To find out more about Lets Communicate Cancer click the link. This resource is free to access but you must register to join BOPA as a free associate member of BOPA.

To access module 5 – A Patient’s story (Jackie’s story) click here.

Latest News

By BOPA Executive Committee on 25th April 2025

NICE TA: Ribociclib with an aromatase inhibitor can be used as an option for the adjuvant treatment of hormone receptor-positive, HER2-negative, early breast cancer at high risk of recurrence in adults.

BOPA have been involved with the following NICE TA: Ribociclib with an aromatase inhibitor can be used as an option for the adjuvant treatment of hormone receptor-positive, HER2-negative, early breast cancer…

Read article
By BOPA IO SAG on 23rd April 2025

Toolkit for Immunotherapy IV to SC switch

Dear all, In the coming months, an increasing number of products traditionally administered intravenously are expected to become available for subcutaneous administration. This shift offers enhanced flexibility for patients; however,…

Read article
By BOPA E&T subcommittee on 17th April 2025

The BOPA Cancer Consultant Pharmacist Credentialing Support Series is back

BOPA are holding a nine month supportive webinar series for pharmacists who are credentialing as consultant pharmacists with the RPS. Join in this relaxed forum to discuss about your portfolio…

Read article
By BOPA research subcommittee on 17th April 2025

Celebration of BOPA member’s recent publications

We are delighted to share that so many of our members have had manuscripts published recently. Here are some that we are aware of but if there are others then…

Read article